CClinicalTrials.gg
RecruitingNCT05357456Updated May 2, 2022

Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study

An observational study in Autonomous Cortisol Secretion, Adrenal Incidentaloma and Non-functioning Adrenal Adenomas, sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. Recruiting at 1 site in China. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-02.

Sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Oct 2021; still recruiting 5 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
62
Ages
20 Years to 65 Years
Sex
All
01

Study summary

This is a single center, prospective, observational study to explore and evaluate the differences on cognitive function and brain function by functional-MRI in autonomous cortisol secretion patients, and the different treatments methods on the cognitive function and brain function in patients with autonomous cortisol secretion

Read the detailed description

Glucocorticoids, mainly cortisol, play a crucial role in the allostatic process of adjustment to stressors and can determine important changes in central nervous system structures. It is well known that Cushing's syndrome (CS) is associated with neurocognitive impairment in about two-thirds of cases. In CS the most frequent reported alterations are memory impairment (about 83% of cases) and reduced concentration (66% of cases) . Unfortunately, these alterations are only partially reversible after the hypercortisolism resolution. As so far, data related to the impact of autonomous cortisol secretion (ACS) on cognitive function are scarce and lack of magnetic resonance indicators. Few studies have studied the cognitive function changes of patients with ACS by surgical and conservative treatment. In the single center, prospective and observational study we aim to explore cognitive functions and brain function by functional-MRI in adrenal incidentaloma patients in relation to the presence of ACS and, secondly, in a group of acs patients, the effect of adrenalectomy on cognitive functions and brain function.

02

Conditions studied

  • Autonomous Cortisol Secretion
  • Adrenal Incidentaloma
  • Non-functioning Adrenal Adenomas

Keywords

  • cognitive function
  • functional MRI
  • treatment
03

In context

Adenoma

657 studies on the registry are indexed under Adenoma; 98 are open to participants now.

This study's planned enrollment of 62 is below the median of 300 across 226 observational studies indexed under Adenoma.

Browse Adenoma studies →

Lead sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is the lead sponsor of 242 studies on the registry; 144 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

autonomous cortisol secretion and non-functioning adrenal adenomas patients

Inclusion criteria

  • age 20-65 years;
  • ≥ 6 years of education;
  • right-handed;
  • complete entire cognitive function tests;
  • adrenal lesions ≥ 1 cm in diameter;
  • patients with non-functioning adrenal adenomas;
  • patients with autonomous cortisol secretion.

Exclusion criteria

Exclusion Criteria:

  • \< 6 years of education;
  • age \< 20 years or > 65 years;
  • maximum diameter of AI \<1cm;
  • active malignancies;
  • with a history of thyroid disease;
  • with a history of acute infection in the last month;
  • central nervous system diseases, including brain trauma, intracranial hemorrhage, acute cerebral infarction, etc;
  • contraindications of MRI examination: such as implantation of metal prosthesis in vivo, claustrophobia, etc;
  • adrenal tuberculosis;
  • suspected or diagnosed adrenocortical carcinoma;
  • unable to complete entire cognitive function tests;
  • current use of steroids or any drugs known to alter steroid synthesis or metabolism in the previous 3 months;
  • clinical Cushing syndrome;
  • Cushing disease;
  • primary hyperaldosteronism;
  • pheochromocytoma;
  • severe impairment of heart, liver, kidney and other organs;
  • pregnant and lactating women
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
62 participants (estimated)
Patient registry
No

Groups and cohorts

  • autonomous cortisol secretion

    Patients admitted to the hospital with adrenal incidentalomas are evaluated for adrenal function, and then ACS patients are diagnosed based on the serum cortisol ≥ 50 nmol/L following the 1 mg dexamethasone suppression test and without any other signs or symptoms of cortisol excess.Patients with ACS will undergo a physical exam, cognitive function test as well as structural and functional brain MRI at baseline and 12 months after their surgery or conservative treatment.

    Behavioral: Cognitive function assessment; functional magnetic resonance imaging · Procedure: laparoscopic adrenal surgery

  • non-functioning adrenal adenomas

    Patients admitted to the hospital with adrenal incidentalomas are evaluated for adrenal function, and then non-functioning adrenal adenomas patients are diagnosed based on the serum cortisol \< 50 nmol/L following the 1 mg dexamethasone suppression test .Patients with non-functioning adrenal adenomas will undergo a physical exam, cognitive function test as well as structural and functional brain MRI at baseline.

    Behavioral: Cognitive function assessment; functional magnetic resonance imaging

Interventions

  • BehavioralCognitive function assessment; functional magnetic resonance imaging

    cognitive function measurement

    Also known as: fMRI

  • Procedurelaparoscopic adrenal surgery

    Only a subgroup of the autonomous cortisol secretion patients will have the laparoscopic adrenal surgery

06

What researchers measure

Primary outcomes

  1. Participants' personal information

    Self-reported information(education in years)

    Time frame: 1 day

  2. Physical assessments

    BMI(body mess index) in kg/m\^2

    Time frame: 1 day

  3. Imaging examinations

    Adrenal adenoma size in cm

    Time frame: 1 day

  4. Montreal Cognitive Assessment (MoCA)

    The MoCA is a Global cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.

    Time frame: 20 minutes

  5. Mini-Mental State Examination (MMSE)

    The MMSE is a cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.

    Time frame: 20 minutes

  6. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    The RBANS is a cognitive screening test designed to assist Health Professionals in evaluation of multiple cognitive subdomains

    Time frame: 1 hour

  7. Rest Functional MRI of the brain function.

    Rs-fMRI

    Time frame: 40 minutes

  8. Screening for adrenal cortisol hypersecretion

    Patients were given 1 mg dexamethasone orally at 24:00 am, and the cortisol levels were measured at 8:00 am the following morning

    Time frame: 1 day

Secondary outcomes

  1. Changes from basline global cognitive functions

    MoCA

    Time frame: 12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]

  2. Changes from basline multiple cognitive subdomains

    RBANS

    Time frame: 12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]

  3. Change from baseline Functional magnetic resonance imagine

    Rs-fMRI

    Time frame: 12 months after the laparoscopic adrenal surgery (for patients with autonomous cortisol secretion who are willing to operate)]

  4. Changes from basline global cognitive functions

    MoCA

    Time frame: 12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]

  5. Changes from basline multiple cognitive subdomains

    RBANS

    Time frame: 12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]

  6. Change from baseline Functional magnetic resonance imagine

    Rs-fMRI

    Time frame: 12 months after the conservative treatment (for patients with autonomous cortisol secretion who are not willing to operate)]

07

Study locations

1 of 1 sites recruiting
  • Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School
    Nanjing, Jiangsu 210008, China
    • Dalong Zhu, MD,PhD · Contact · zhudalong@nju.edu.cn · 86-25-83-105302
    • Ping Li, MD,PhD · Contact · li78321@yeah.net · 86-25-83-105302
    • Dalong Zhu, MD,PhD · Principal investigator
    • Ping Li, MD,PhD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05357456
Lead sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Responsible party
Dalong Zhu (Chief Physician, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School) — Principal investigator
First posted
May 2, 2022
Start date
Oct 1, 2021
Primary completion
Oct 1, 2024 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
May 2, 2022

Study contacts

Dalong Zhu, MD,PhD
Contact
zhudalong@nju.edu.cn
86-25-83-105302
PIng Li, MD,PhD
Contact
li78321@yeah.net
86-25-83-105302
Dalong Zhu, MD,PhD
principal investigator · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion